Intevac (NASDAQ:IVAC) reported quarterly sales of $9.30 million which beat the analyst consensus estimate of $8.00 million by 16.25 percent. This is a 32.67 percent decrease over sales of $13.81 million the same period last year.
Potential For Accelerated Growth In Penumbra Despite Product Launch Delays: Analysts’ Positive Outlook Post Q2 Results
Truist Securities analyst Richard Newitter reiterated a Buy rating on Penumbra, Inc. (NYSE: PEN),
